Loading…

Medical Research Finder

Legal Notice
Privacy
Terms of Use

Gut microbiota / Evidence-based microbiome knowledge (incl. AI chat)
Prebiotics, Probiotics, FMT / Manipulators of the Intestinal Microbiota

AuthorsReferences (Sources)

meRfi® AI Chat

Esophageal cancer

Welcome to meRfi-GM!

Please register to continue your trial period!

meRfi-GM provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.

Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.

Start your free trial and transform your understanding of the gut microbiota today!

(Login)

Navigation

Esophageal squamous-cell carcinoma (ESCC) and Esophageal adenocarcinoma (EAC) are the two primary histological subtypes but have yet to vastly differ in management.
Rogers et al. 2022 Expert Opinion on Therapeutic Targets 26(2): 107-117

The prognosis of patients with advanced esophageal cancer (EC) remains poor, and there are limited effective therapeutic agents for Esophageal cancer.
Harada et al. 2022 Future Oncol. 18(18): 2311-2319

Patients with esophageal cancer are at high risk for malnutrition.
Wang et al. 2020ad Future Oncology 16: 2949–2957

Worldwide, esophageal cancer (EC) is the seventh leading cause of…

References (Sources)

An expert opinion on esophageal cancer therapy
Cohen & Ajani, 2011
Review
Enteral nutritional support in patients undergoing chemoradiotherapy for esophageal carcinoma
Wang et al. 2020ad Future Oncology 16: 2949–2957
Esophageal cancer: emerging therapeutics
Rogers et al. 2022 Expert Opinion on Therapeutic Targets 26(2): 107-117
Review
Pembrolizumab for the treatment of advanced esophageal cancer
Harada et al. 2022 Future Oncol. 18(18): 2311-2319
Review

AI Chat

12/16/2025

Chat with our artificial intelligence:

Start chat!

Esophageal cancer

Welcome to meRfi-GM!

Navigation

Contents

References (Sources)

AI Chat

Links